3-Phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 100mg

Ethyl 3,4-diaminobenzoate, 95.0%, 5g

2-(4-Aminophenyl)propan-2-ol, 95+%, 1g

Ethyl 5-acetoxy-6-bromo-2-(bromomethyl)-1-methyl-1H-indole-3-carboxylate, 95.0%, 25g

ethyl 5-(3-nitrophenyl)-1H-pyrazole-3-carboxylate, 95.0%, 2g

Bis(2-ethylhexyl) phosphite, 95.0%, 5g

(S)-Citalopram Oxalate>98.0%(HPLC)(T)1g

Analytical and precision balance PR series Models with internal adjustment, not certified, 0.01 g, 4200 g, PR4202

1-(2,3-dimethylphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 5g

Methyl 2-chloro-4,5-dimethoxybenzoate, 98.0%, 5g

2-amino-N-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide, 95.0%, 10g

(Z)-2-Acetamido-3-phenylacrylic acid, 95.0%, 25g

cis-4-Hydroxy-D-proline>98.0%(HPLC)(T)5g